HomeHealth, Fitness & Diet BooksClinical Manual of Addiction Psychopharmacology, Second Edition
Skip to product information
1 of 1

Clinical Manual of Addiction Psychopharmacology, Second Edition

paperbackNovember 6, 2013
Regular price $65.07 USD
Regular price Sale price $65.07 USD
Sale Sold out
Shipping calculated at checkout.
Secure Checkout
Quality Guaranteed
New In Stock
ISBN-13: 9781585624409 ISBN-10: 1585624403
Publisher
American Psychiatric Association
Binding
paperback
Published
November 6, 2013
Weight
0.5 lbs
Dimensions
20.30×3.20×14.00 cm

About this book

Clinical Manual of Addiction Psychopharmacology, Second Edition by Henry R. Kranzler M.D.. paperback edition. ISBN: 9781585624409.

Psychopharmacology is a swiftly evolving field, with new drugs coming onto the market and existing drugs being approved for new treatments at a rapid pace. This new edition of Clinical Manual of Addiction Psychopharmacology offers current information on the pharmacology of the major classes of drugs related to addiction, as well as the latest pharmacological treatment of dependence on these drugs. Advances have been made in the treatment of opioid, alcohol, and tobacco dependence, in particular, and these chapters have been thoroughly updated. In addition, the manual reflects recent research findings and evidence-based perspectives on the pharmacological actions of other drugs of abuse. The editors have adopted a therapeutic focus that will prove indispensable to clinicians challenged to identify effective pharmacotherapy treatments for their patients with substance use disorders. For example, the importance of identifying co-occurring medical problems and psychiatric syndromes is emphasized to avoid undermining the therapeutic effects of treatment, and the efficacy of combining nonpharmacological treatment, such as psychotherapy, is also explored. Prescribing clinicians, social workers, and other mental health practitioners will find Clinical Manual of Addiction Psychopharmacology invaluable in their work with individuals with substance-related disorders.